Loading
TNO155 is a small-molecule inhibitor from Novartis Pharmaceuticals, in registered phase 2 trials for non-small-cell lung cancer, small-cell lung cancer.
TNO155 is listed on ClinicalTrials.gov as an intervention in 1 registered phase 2 trial sponsored by Novartis Pharmaceuticals, in non-small-cell lung cancer, small-cell lung cancer. Described in the registry record as a shp2 inhibitor; the trial entries below carry the sponsor's wording. OnCo records the agent from the registry alone; approvals, results and the sponsor's own description will follow as they are published.
Described in the registry record as a shp2 inhibitor; the trial entries below carry the sponsor's wording.
1.TNO155 slips into a pocket on its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"TNO155" OR ABSTRACT:"TNO155") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about TNO155, not a curated reading list.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other, Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation, Novartis, Non-small-cell lung cancer and the tag pipeline.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.
Shares Novartis and the tags pipeline, registry-only.
Shares Small-cell lung cancer, Non-small-cell lung cancer and the tags pipeline, registry-only.